Vijay Pande, a basic companion at Andreessen Horowitz who based the agency’s a16z Bio+ Health technique, introduced that he’s stepping down from his function.
Since its founding in 2014, a16z Bio+ Health has raised 4 funds of almost $3 billion every, together with a $1.5 billion fund that closed in 2022. However, it’s now looking for a a lot smaller $750 million fifth fund, The Wall Street Journal reported. In January, a16z Bio+ Health introduced that it’s going to handle a $500 million biotech fund funded by pharmaceutical big Eli Lilly.
a16z Bio + Health backs digital well being startups and firms on the intersection of AI, computation, and biology.
Pande’s investments embrace Devoted Health, an individualized medical plan supplier; Function Health, a customized lab testing startup; and Freenome, an organization aiming to detect most cancers by means of blood attracts. Before becoming a member of Andreessen Horowitz, Pande was a professor of chemistry, structural biology, and pc science at Stanford University.
The remaining companions on the a16z Bio + Health workforce are Jorge Conde, Julie Yoo, and Vineeta Agarwala.
